Health Condition 1: F209- Schizophrenia, unspecified
Conditions
Interventions
Intervention1: Multigenetic pharmacogenomic antipsychotic panel test: Sixty patients will be randomly divided into two groups: group A will receive standard treatment according, and group B will recei
Sponsors
Dr Amrita Kumari Pandey
Eligibility
Inclusion criteria
Inclusion criteria: 1.ICD-10 or 11 criteria for schizophrenia 2.Positive and Negative Syndrome Scale (PANSS) more than 60 score 3.Patient or legally authorized representative willing to give informed consent 4.Two generations of the patient living in northern India 5.Schizophrenic patients who have not received any psychotropics
Exclusion criteria
Exclusion criteria: 1.Concurrent substance use disorders 2.Neurological conditions 3.Other comorbid axis I psychiatric diagnoses 4.Severe unstable organic illnesses 5.Not able to give consent 6.Pregnant or lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time course of schizophrenia severity which will be measured by the percentage PANSS score change from baseline and at the end of 3 monthTimepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Response or remission rate will be calculated at each time point (1, 2, 3 months) using the PANSS score Early remission: change of 20 % in PANSS score Response: more than a 50 % change in PANSS Complete remission: less than 3 PANSS score Timepoint: 18 months | — |
Countries
India
Contacts
Public ContactDR Farhan Ahmad Khan
Jawaharlal Nehru Medical College
Outcome results
None listed